Abstract
Despite the increasing success of lung transplantation as the mainstay therapeutic modality for end-stage lung disease, the 1-year survival rate after lung transplantation remains 80% and primary graft dysfunction (PGD) accounts for 30% of mortality. Ischemia-reperfusion injury has been identified as one of the main causes of PGD, and thus significant efforts have been made to optimize the methods for lung preservation in an attempt to minimize lung injury during the period of ischemia. The composition of the lung preservation solution used in the pulmonary artery flush has been considered to be the key to successful lung preservation, and many lung transplant programs have been shifting the use of the preservation solution from the intracellular fluid type to the extracellular fluid type because of preferable posttransplant lung function with the latter. This review summarizes the experimental and clinical studies on lung preservation, particularly focusing attention on the preservation solution being employed for clinical lung transplantation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
ISHLT home page on the Internet, http://www.ishlt.org.
Toronto Lung Transplant Group: unilateral lung transplantation for pulmonary fibrosis. N Engl J Med 1986;314:1140–1145.
Date H, Yamamoto H, Yamashita M, Aoe M, Kubo K, Shimizu N. One year follow-up of the first bilateral livingdonor lobar lung transplantation in Japan. Jpn J Thorac Cardiovasc Surg 2000;48:648–651.
Miyoshi S, Minami M, Ohta M, Okumura M, Takeda S, Matsuda H. Single lung transplantation from a brain-dead donor for a patient with idiopathic pulmonary fibrosis. A breakthrough after new legislation in Japan. Jpn J Thorac Cardiovasc Surg 2001;49:398–403.
Matumura Y, Okada Y, Sado T, Fujimura S, Kondo T. First brain dead donor lung transplantation in Japan-right single lung transplant. Transplantation Now 2000;13:418–425.
The Japanese Society of Lung and Heart-Lung Transplantation home page on the Internet, http://www.hai-isyoku.jp/index.html.
Christie JD, Carby M, Bag R, Corris P, Hertz, M, Weill, D. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005;24:1454–1459.
Bernard GR. Artigas A. Brigham KL. Carlet J. Falke K. Hudson L, et al. The American European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818–824.
Novick RJ, Menkis A, McKenzie N. New trend in lung preservation: a cllective review. J Heart Lung Transplant 1992;11:377–392.
De Perrot M, Keshavjee S. Lung preservation. Semin Thorac Cardiovasc Surg 2004;16:300–308.
De Perrot M, Bonser RS, Dark J, Kelly RF, McGiffin D, Menza R, et al. Report of the ISHLT Working Group on Primary Graft Dysfunction part III: donor related risk factor and markers. J Heart Lung Transplant 2005;24:1460–1467.
Baumgartner WA, Williams GM, Fraser CD Jr, Cameron DE, Gardner TJ, Burdick JF, et al: Cardiopulmonary bypass with profound hypothermia; An optimal preservation method for multiorgan procurement. Transplantation 1989;47:123–127.
Hopkinson DN, Bhabra MS, Hooper TL. Pulmonary graft preservation: a worldwide survey of current clinical practice. J Heart Lung Transplant 1998;17:525–531.
Novic RJ, Reid KR, Denning L, Duplan J, Menkis AH, Mckenzie FN. Prolonged preservation of canine lung allografts: the role of prostaglandins. Ann Thorac Surg 1991;51:853–859.
Struber M, Hohlfeld JM, Kofidis T, Warnecke G, Niedermeyer J, Sommer SP, et al. Surfactant function in lung transplantation after 24 hours of ischemia: advantage of retrograde flush perfusion for preservation. J Thorac Cardiovasc Surg. 2002;123:98–103.
Venuta F, Rendina EA, Bufi M, Della Rocca G, De Giacomo T, Costa MG, et al. Preimplantation retrograde pneumoplegia in clinical lung transplantation. J Thorac Cardiovasc Surg 1999;118:107–114.
Vieth FJ, Sinha SBP, Graves JS, Boley SJ, Dougherty JC. Ischemic tolerance of the lung: the effect of ventilation and inflation. J Thorac Cardiovasc Surg 1971;61:804–810.
Date H. Matsumura A. Manchester JK. Cooper JM. Lowry OH. Cooper JD. Changes in alveolar oxygen and carbon dioxide concentration and oxygen consumption during lung preservation. The maintenance of aerobic metabolism during lung preservation. J Thorac Cardiovasc Surg 1993;105:492–501.
Fukuse T. Hirata T. Nakamura T. Kawashima M. Hitomi S. Wada H. Influence of deflated and anaerobic conditions during cold storage on rat lungs. Am J Respir Crit Care Med 1999;160:621–627.
Sakuma T. Tsukano C. Ishigaki M. Nambu Y. Osanai K. Toga H, et al. Lung deflation impairs alveolar epithelial fluid transport in ischemic rabbit and rat lungs. Transplantation 2000;69:1785–1793.
Kondo T, Fujimura S, Yamauchi A, Okabe T, Handa M, Shionozaki H, et al. Successful preservation of canine lung for 24 hours by simple cooling method. Jpn J Transplant 1984;19: 295–299.
Fujimura S, Handa M, Kondo T, Ichinose T, Shiraishi Y, Nakata T. Successful 48-hour simple hypothermic preservation of canine lung transplants. Transplant Proc 1987;19:1334–1336.
Handa M, Fujimura S, Kondo T, Ichinose T, Shiraishi Y, Nakada T. A study of preservation solution for 48-and 96-hour simple hypothermic storage of canine lung transplants. Tohoku J Exp Med 1989;159:205–214.
Ichinose T, Handa M, Matsumura Y, Sasaki H, Okada Y, Fujimura S. Hypothermic preservation of the transplanted lung from non-heart beating donors in Dogs. Jap J Transplant 1992;27:300–308.
Okada Y, Marchevsky AM, Zuo X-J, Pass J, Kass RM, Matloff JM, et al. Accumulation of platelets in rat syngeneic lung transplants: a potential factor responsible for preservation-reperfusion injury. Transplantation 1997;64:801–806.
Colombat M. Castier Y. Leseche G. Rufat P. Mal H. Thabut G, et al. Early expression of adhesion molecules after lung transplantation: evidence for a role of aggregated P-selectinpositive platelets in human primary graft failure. J Heart Lung Transplant 2004;23:1087–1092.
Yamazaki F, Yokomise H, Keshavjee SH, Miyoshi S, Cardoso PF, Slutsky AS, et al. The superiority of an extracellular fluid solution over Euro-Collins’ solution for pulmonary preservation. Transplantation 1990;49:690–694.
Keshavjee SH, Yamazaki F, Yokomise H, Cardoso PF, Mullen JBM, Slutsky AS, et al. The role of dextran 40 and potassium in extended hypothermic lung preservation for transplantation. J Thorac Cardiovasc Surg 1992;103:314–325.
Date H, Matsumura A, Manchester JK, Obo H. Lima O, Cooper JM Sundaresan S, et al. Evaluation of lung metabolism during successful twenty-four-hour canine lung preservation. J Thorac Cardiovasc Surg 1993;105:480–491.
Okada Y, Kondo T. Impact of lung preservation solutions, Euro-Collins vs. low-potassium dextran, on early graft function: a review of five clinical studies. Ann Thorac Cardiovasc Surg 2006;12:10–14.
Thabut G, Vinatier I, Brugiere O, Leseche G, Loirat P, Sisson A, et al. Influence of preservation solution on early graft failure in clinical lung transplantation. Am J Respir Crit Care Med 2001;164:1204–1208.
Omasa M, Hasegawa S, Bando T, Hanaoka N, Yoshimura T, Nakamura T, et al. Appkication of ET-Kyoto solution in clinical lung transplantation. Ann Thorac Surg 2004;77:338–339.
Cypel M, Yeung JC, Hirayama S, Rubacha M, Fischer S, Anraku M, et al. Technique for prolonged Normothermic ex vivo lung perfusion. J Heart Lung Transplant 2008;27:1319–1325.
Author information
Authors and Affiliations
Corresponding author
Additional information
This review was submitted at the invitation of the editorial committee.
Rights and permissions
About this article
Cite this article
Okada, Y., Kondo, T. Preservation solution for lung transplantation. Gen Thorac Cardiovasc Surg 57, 635–639 (2009). https://doi.org/10.1007/s11748-009-0492-3
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-009-0492-3